Iatrogenic Deficiencies in ICU Patients With Prolonged Continuous Renal Replacement Therapy
NCT ID: NCT06983197
Last Updated: 2025-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
30 participants
OBSERVATIONAL
2025-06-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Samples will be analyzed for concentrations of trace elements, vitamins and amino acids.
10 adult ICU patients treated for two weeks without renal replacement therapy will be sampled at one time point to serve as controls.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Amino Acid Supplementation in Continuous Renal Replacement Therapy
NCT06835816
Timing of Renal Replacement Therapy in the Critically Ill Patients
NCT03629977
Amino Acid Loss During Continuous Renal Replacement Therapy
NCT06659835
Renal Physiology During Continuous Renal Replacement Therapy
NCT04114747
Analysis of Clinical Outcomes in Patients Undergoing Acute Dialysis Therapy at Intensive Care Units
NCT01039753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRRT patients
Patients, all ages, that receive CRRT for at least five days.
blood test
Blood samples are drawn every 3-5 days in the RRT group but only once in the control group
Non-CRRT patient
Adult patients, \>17 yo, treated in the ICU for 10-15 days without renal replacement therapy
blood test
Blood samples are drawn every 3-5 days in the RRT group but only once in the control group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood test
Blood samples are drawn every 3-5 days in the RRT group but only once in the control group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\- ICU care 10-15 days without any dialysis treatment
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonathan Grip
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan Grip, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska University Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-07642-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.